A comprehensive view of capsules/pills/tablets. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Kibow Pharmaceuticals recruiting 630 patients for Phase 2b global clinical trial of oral US-APR2020 live biotherapeutic to treat chronic kidney disease; CKD treatment for US Medicare patients cost US$87.2B in 2019 according to CDC data

Aprea Therapeutics acquires Atrin Pharmaceuticals in stock-for-stock transaction; acquisition shifts Aprea’s focus to oral ATRN-119 ATR inhibitor to treat solid tumors; monotherapy, combination therapy Phase1/2 studies planned for the drug

Cullinan Oncology, Taiho Pharmaceutical to co-develop, commercialize oral CLN-081/TAS6417 cancer treatment, with Taiho to commercialize drug outside US, China; Taiho acquires Cullinan’s Cullinan Pearl subsidiary for US$405.0M

FDA accepts Angion’s IND application for clinical development of biopharmaceutical ANG-3070 oral tyrosine kinase inhibitor to treat idiopathic pulmonary fibrosis; Angion to start enrollment in Phase 1B study, with 20 patients in crossover design trial

Rutgers University enrolling up to 150 children with symptomatic cases of COVID-19 for Phase 2/3 trial of Pfizer-BioNTech’s oral Paxlovid nirmatrelvir, ritonavir antiviral treatment; the university is one of multiple worldwide sites in study

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count